Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06263023 · ClinicalTrials.gov registry record

A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation

A clinical trial of Organ Preservation, sponsored by 34 Lives, PBC.

Active
Registry status
80
Enrollment target
8
Study locations

NCT06263023 is a study of Organ Preservation that is active but no longer recruiting, run by 34 Lives, PBC. The registered enrollment target is 80 participants. The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06263023, a study of Organ Preservation, is active but no longer recruiting, sponsored by 34 Lives, PBC.

ACTIVE NOT RECRUITING
Registry status
80 participants
Enrollment target
8
Study locations

Study Summary

This is a study to collect information to assess if transporting hard-to-place (HTP) donor kidneys to a central preservation and assessment facility with dedicated organ assessment capabilities increases allocation success to transplant hospitals.

Conditions Studied

Interventions

  • OTHER Sub-Normothermic Machine Preservation and Assessment

Study Locations (8)

New York

  • Erie County Medical Center - Buffalo
  • New York University Langone - New York
  • The Mount Sinai Hospital - New York

Illinois

  • Edward Hines, Jr. VA Hospital - Chicago

Indiana

  • Indiana University Health - Indianapolis

Missouri

  • Barnes-Jewish Hospital - St Louis

North Carolina

  • Duke University - Durham

Wisconsin

  • University of Wisconsin School of Medicine and Public Health - Madison

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-04-19
Est. Completion 2028-03-25

Sponsor

34 Lives, PBC

1 total trials

What the Registry Record Tells You About NCT06263023

The ClinicalTrials.gov registry entry for NCT06263023 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 34 Lives, PBC, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Organ Preservation appearing as the primary indexed condition, and to 1 intervention - of which Sub-Normothermic Machine Preservation and Assessment is the first listed.

NCT06263023 reports 8 study locations spanning 6 distinct geographic areas - top geographies include New York, Illinois, Indiana.

Frequently Asked Questions

What is clinical trial NCT06263023 about?

NCT06263023 is a clinical study titled "A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation". This is a study to collect information to assess if transporting hard-to-place (HTP) donor kidneys to a central preservation and assessment facility with dedicated organ assessment capabilities increases allocation success to transplant hospitals.

What is the current status of trial NCT06263023?

This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2024-04-19. Estimated completion is 2028-03-25.

What conditions does trial NCT06263023 study?

This clinical trial studies the following conditions: Organ Preservation.

What interventions are being tested in trial NCT06263023?

The interventions under investigation include: Sub-Normothermic Machine Preservation and Assessment (OTHER).

Who is sponsoring clinical trial NCT06263023?

This trial is sponsored by 34 Lives, PBC, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06263023 being conducted?

This trial has 8 study locations across Illinois, Indiana, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Organ Preservation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.